Researchers led by Tao Dong reported that some clinical isolates of Pseudomonas aeruginosa carry an additional H4 type VI secretion system beyond the three typically found in the species.
In the clinical isolate LYSZa7, the native H4-T6SS was found to be silent or transcriptionally silent under standard laboratory conditions.
Rewiring the promoters activated the H4 system and showed that it functions as a secretion apparatus with antibacterial activity, and one analysis also noted cytotoxicity.
The study identified TseMt as a major H4-associated antibacterial effector that acts in the periplasm and forms ion-conducting pores in membranes or lipid bilayers.
A cryo-EM structure of TseMt revealed a compact three-domain architecture, and one analysis reported a 3.0-angstrom single-particle structure.
The work also linked TseMt activity to a DUF4123 chaperone, VgrG4b, and PAAR4 in the delivery pathway.
A quick read on shared facts, changing details, and different emphasis.
All of the supplied analyses agree that clinical Pseudomonas aeruginosa can carry an H4 type VI secretion system that is normally silent, and that experimental promoter rewiring reveals it to be functional. They also agree that TseMt is the key effector and that structural work showed a three-domain protein architecture.
The main unresolved point is how broadly this H4 system is distributed across clinical isolates and under what natural conditions it becomes active, since the evidence here comes from laboratory activation in LYSZa7. The exact scope of the antibacterial and cytotoxic effects may also be refined as further studies build on the structural and mechanistic findings.
Swipe through the perspectives. Labels describe coverage framing, not truth or quality.
The reporting is centered on a laboratory study led by Tao Dong and colleagues on the H4-T6SS found in certain clinical isolates of Pseudomonas aeruginosa. Across the analyses, the native system is described as silent under ordinary testing, while promoter rewiring exposes antibacterial function and, in one account, cytotoxicity. The key mechanistic takeaway is that TseMt behaves as a pore-forming effector in the periplasm, with cryo-EM supporting a three-domain structural model. The reporting also mentions associated components in the delivery pathway, including DUF4123, VgrG4b, and PAAR4.
The latest eight dated reports, from earliest to newest.
The National Law Review
Attributed summaries from official party channels. These are claims, not independent reporting or fact checks.
Scan each source take, then open the original article.
This article reports on a study led by Tao Dong and colleagues regarding the fourth type VI secretion system in clinical isolates of Pseudomonas aeruginosa. Researchers found that while the H4-T6SS in the LYSZa7 isolate is silent under standard laboratory conditions, rewiring its promoters demonstrates that it functions as an active secretion apparatus. The study identifies TseMt as a major antibacterial effector that forms ion-conducting pores, providing the first functional validation of this accessory system.
This news release details research led by Tao Dong and collaborators on the fourth type VI secretion system found in certain clinical isolates of Pseudomonas aeruginosa. The investigators discovered that the native H4-T6SS is transcriptionally silent during standard testing, but experimental promoter rewiring activates the system to exhibit antibacterial activity and cytotoxicity. Furthermore, the work identifies TseMt as an effector protein that operates in the periplasm to form ion-conducting pores, offering mechanistic insights into the H4 system.
Researchers led by Tao Dong report that the fourth type VI secretion system found in some clinical Pseudomonas aeruginosa isolates is a functional apparatus when activated. The study details how the H4-T6SS deploys TseMt, an antibacterial effector that forms ion-conducting pores in lipid bilayers. Using the clinical isolate LYSZa7, the team demonstrated antibacterial and cytotoxic activities after rewiring the system's silent promoters. The findings provide new mechanistic insights into bacterial secretion systems and pathogen competition.